Review: Steroid Use in Patients With Acute Spinal Cord Injury and Guideline Update

Overview

Journal Korean J Neurotrauma

Date 2022 May 13

PMID 35557630

Authors

Byung-Jou Lee

Je Hoon Jeong

Affiliations

Soon will be listed here.

Abstract

Acute spinal cord injury (SCI) is a devastating condition that causes enormous damage to a patient's physical, mental, and economic situation and requires a multidisciplinary approach to treatment. Research on SCI has been performed for a long time, and the management of SCI has developed dramatically in recent decades as a mechanism of injury and the pathophysiology of SCI have been revealed from the primitive stage in the past. In the treatment of patients with acute SCI, there is a lot of debate regarding surgical treatment strategies and pharmacological management, such as steroid use. In particular, the efficacy of steroid use, such as methylprednisolone sodium succinate, has been increasing and decreasing and is still intensely debated. The practice guidelines reported so far for this are also at the "suggest" stage with weak recommendations. Therefore, this review aims to summarize the effects of steroid use on SCI. This review provides an overview of current practical guidelines and clinical studies on steroid use in patients with SCI.

Citing Articles

Pectin-Zein-IPA nanoparticles promote functional recovery and alleviate neuroinflammation after spinal cord injury.

Chen X, Wang B, Al Mamun A, Du K, Wang S, Hu Q J Nanobiotechnology. 2025; 23(1):152.

PMID: 40016738 PMC: 11869623. DOI: 10.1186/s12951-025-03224-1.

Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps.

Jung J, Jeong J, Ko M, Lee B, Kwon W, Jeon S Korean J Neurotrauma. 2025; 20(4):234-245.

PMID: 39803345 PMC: 11711022. DOI: 10.13004/kjnt.2024.20.e45.

Severe Transverse Myelitis Following Ankle Surgery Potentially Unmasking Late-Onset Systemic Lupus Erythematosus.

Jordan H, Sahni S, Nguyen M, Moradi M, Mumtaz S, Johnson L Cureus. 2024; 16(11):e74006.

PMID: 39703303 PMC: 11658893. DOI: 10.7759/cureus.74006.

Synergistic effects of human umbilical cord mesenchymal stem cells/neural stem cells and epidural electrical stimulation on spinal cord injury rehabilitation.

Mu Z, Qin J, Zhou X, Wang K Sci Rep. 2024; 14(1):26090.

PMID: 39478010 PMC: 11526023. DOI: 10.1038/s41598-024-75754-x.

Symposium 2024: A Starting Point for a Leap Forward.

Oh H Korean J Neurotrauma. 2024; 20(3):135-136.

PMID: 39372114 PMC: 11450334. DOI: 10.13004/kjnt.2024.20.e31.

References

Braughler J . Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J Neurochem. 1985; 44(4):1282-8. DOI: 10.1111/j.1471-4159.1985.tb08755.x. View

Fehlings M, Tator C . The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol. 1995; 132(2):220-8. DOI: 10.1016/0014-4886(95)90027-6. View

Badhiwala J, Ahuja C, Fehlings M . Time is spine: a review of translational advances in spinal cord injury. J Neurosurg Spine. 2019; 30(1):1-18. DOI: 10.3171/2018.9.SPINE18682. View

Venkatesh K, Ghosh S, Mullick M, Manivasagam G, Sen D . Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell Tissue Res. 2019; 377(2):125-151. DOI: 10.1007/s00441-019-03039-1. View

Liu M, Wu W, Li H, Li S, Huang L, Yang Y . Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J Spinal Cord Med. 2014; 38(6):745-53. PMC: 4725808. DOI: 10.1179/2045772314Y.0000000224. View

Bracken M, Shepard M, COLLINS W, Holford T, Young W, Baskin D . A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990; 322(20):1405-11. DOI: 10.1056/NEJM199005173222001. View

Rabinstein A . Traumatic Spinal Cord Injury. Continuum (Minneap Minn). 2018; 24(2, Spinal Cord Disorders):551-566. DOI: 10.1212/CON.0000000000000581. View

Hausmann O . Post-traumatic inflammation following spinal cord injury. Spinal Cord. 2003; 41(7):369-78. DOI: 10.1038/sj.sc.3101483. View

Li S, Mealing G, Morley P, Stys P . Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J Neurosci. 1999; 19(14):RC16. PMC: 6783104. View

10.

Faden A . Therapeutic approaches to spinal cord injury. Adv Neurol. 1997; 72:377-86. View

11.

Brazda N, Muller H . Pharmacological modification of the extracellular matrix to promote regeneration of the injured brain and spinal cord. Prog Brain Res. 2009; 175:269-81. DOI: 10.1016/S0079-6123(09)17518-0. View

12.

Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H . Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976). 2001; 26(4):426-30. DOI: 10.1097/00007632-200102150-00020. View

13.

Werndle M, Zoumprouli A, Sedgwick P, Papadopoulos M . Variability in the treatment of acute spinal cord injury in the United Kingdom: results of a national survey. J Neurotrauma. 2011; 29(5):880-8. DOI: 10.1089/neu.2011.2038. View

14.

Forgione N, Fehlings M . Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg. 2013; 82(3-4):e535-9. DOI: 10.1016/j.wneu.2013.01.009. View

15.

Chen M, Huber A, van der Haar M, Frank M, Schnell L, Spillmann A . Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000; 403(6768):434-9. DOI: 10.1038/35000219. View

16.

Schanne F, Kane A, Young E, Farber J . Calcium dependence of toxic cell death: a final common pathway. Science. 1979; 206(4419):700-2. DOI: 10.1126/science.386513. View

17.

Druschel C, Schaser K, Schwab J . Current practice of methylprednisolone administration for acute spinal cord injury in Germany: a national survey. Spine (Phila Pa 1976). 2013; 38(11):E669-77. DOI: 10.1097/BRS.0b013e31828e4dce. View

18.

Ducker T, Hamit H . Experimental treatments of acute spinal cord injury. J Neurosurg. 1969; 30(6):693-7. DOI: 10.3171/jns.1969.30.6.0693. View

19.

Cafferty W, Duffy P, Huebner E, Strittmatter S . MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci. 2010; 30(20):6825-37. PMC: 2883258. DOI: 10.1523/JNEUROSCI.6239-09.2010. View

20.

Wang Y, Wang H, Tao Y, Zhang S, Wang J, Feng X . Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience. 2014; 266:91-101. DOI: 10.1016/j.neuroscience.2014.02.007. View